{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T19:22:20Z","timestamp":1792783340316,"version":"4.5.0"},"reference-count":39,"publisher":"Springer Science and Business Media LLC","license":[{"start":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T00:00:00Z","timestamp":1788307200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T00:00:00Z","timestamp":1788307200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"National Clinical Key Specialty Construction Project","award":["10000015Z155080000004"],"award-info":[{"award-number":["10000015Z155080000004"]}]},{"DOI":"10.13039\/501100003399","name":"Science and Technology Commission of Shanghai Municipality","doi-asserted-by":"publisher","award":["23J41900200"],"award-info":[{"award-number":["23J41900200"]}],"id":[{"id":"10.13039\/501100003399","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Clinical Research Center for RASopathy, Pediatric College, Shanghai Jiao Tong University School of Medicine","award":["ELYZX202107"],"award-info":[{"award-number":["ELYZX202107"]}],"id":[{"id":"https:\/\/ror.org\/0220qvk04","id-type":"ROR","asserted-by":"crossref"}]},{"name":"National Key R&D Program of China","award":["2023YFC2706305"],"award-info":[{"award-number":["2023YFC2706305"]}]},{"DOI":"10.13039\/501100019978","name":"Shanghai Pudong New Area Health Commission","doi-asserted-by":"publisher","award":["PWZxq2022-07"],"award-info":[{"award-number":["PWZxq2022-07"]}],"id":[{"id":"10.13039\/501100019978","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["World J Pediatr"],"DOI":"10.1007\/s12519-026-01092-9","type":"journal-article","created":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T18:45:32Z","timestamp":1788374732000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Phenotypic and genotypic characteristics of pediatric patients with neurofibromatosis type 1: a 12-year single-center cohort study"],"prefix":"10.1007","author":[{"given":"Zhi-Ying","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tian","family":"Wen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bi-Yun","family":"Feng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yang","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jia-Yue","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ting-Ting","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ru-En","family":"Yao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2186-759X","authenticated-orcid":false,"given":"Xiu-Min","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,9,2]]},"reference":[{"key":"1092_CR1","doi-asserted-by":"publisher","first-page":"904","DOI":"10.1038\/jid.2014.465","volume":"135","author":"E Uusitalo","year":"2015","unstructured":"Uusitalo E, Lepp\u00e4virta J, Koffert A, Suominen S, Vahtera J, Vahlberg T, et al. Incidence and mortality of neurofibromatosis: a total population study in Finland. J Invest Dermatol. 2015;135:904\u20136. https:\/\/doi.org\/10.1038\/jid.2014.465.","journal-title":"J Invest Dermatol"},{"key":"1092_CR2","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1111\/j.1399-0004.2006.00639.x","volume":"70","author":"AB Trov\u00f3-Marqui","year":"2006","unstructured":"Trov\u00f3-Marqui AB, Tajara EH. Neurofibromin: a general outlook. Clin Genet. 2006;70:1\u201313. https:\/\/doi.org\/10.1111\/j.1399-0004.2006.00639.x.","journal-title":"Clin Genet"},{"key":"1092_CR3","doi-asserted-by":"publisher","first-page":"851","DOI":"10.1016\/0092-8674(90)90151-4","volume":"63","author":"R Ballester","year":"1990","unstructured":"Ballester R, Marchuk D, Boguski M, Saulino A, Letcher R, Wigler M, et al. The NF1 locus encodes a protein functionally related to mammalian GAP and yeast IRA proteins. Cell. 1990;63:851\u20139. https:\/\/doi.org\/10.1016\/0092-8674(90)90151-4.","journal-title":"Cell"},{"key":"1092_CR4","doi-asserted-by":"publisher","DOI":"10.1038\/nrdp.2017.4","volume":"3","author":"DH Gutmann","year":"2017","unstructured":"Gutmann DH, Ferner RE, Listernick RH, Korf BR, Wolters PL, Johnson KJ. Neurofibromatosis type 1. Nat Rev Dis Primers. 2017;3:17004. https:\/\/doi.org\/10.1038\/nrdp.2017.4.","journal-title":"Nat Rev Dis Primers"},{"key":"1092_CR5","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1016\/j.pediatrneurol.2023.08.036","volume":"149","author":"Y Bildirici","year":"2023","unstructured":"Bildirici Y, Kocaaga A, Karademir-Arslan CN, Yimenicioglu S. Evaluation of molecular and clinical findings in children with neurofibromatosis type 1: identification of 15 novel variants. Pediatr Neurol. 2023;149:69\u201374. https:\/\/doi.org\/10.1016\/j.pediatrneurol.2023.08.036.","journal-title":"Pediatr Neurol"},{"key":"1092_CR6","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1136\/jmg.2006.045906","volume":"44","author":"RE Ferner","year":"2007","unstructured":"Ferner RE, Huson SM, Thomas N, Moss C, Willshaw H, Evans DG, et al. Guidelines for the diagnosis and management of individuals with neurofibromatosis 1. J Med Genet. 2007;44:81\u20138. https:\/\/doi.org\/10.1136\/jmg.2006.045906.","journal-title":"J Med Genet"},{"key":"1092_CR7","doi-asserted-by":"publisher","first-page":"1035","DOI":"10.1016\/j.mcna.2019.07.004","volume":"103","author":"KI Ly","year":"2019","unstructured":"Ly KI, Blakeley JO. The diagnosis and management of neurofibromatosis type 1. Med Clin North Am. 2019;103:1035\u201354. https:\/\/doi.org\/10.1016\/j.mcna.2019.07.004.","journal-title":"Med Clin North Am"},{"key":"1092_CR8","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1111\/j.1600-0749.2004.00206.x","volume":"18","author":"S De Schepper","year":"2005","unstructured":"De Schepper S, Boucneau J, Lambert J, Messiaen L, Naeyaert JM. Pigment cell-related manifestations in neurofibromatosis type 1: an overview. Pigm Cell Res. 2005;18:13\u201324. https:\/\/doi.org\/10.1111\/j.1600-0749.2004.00206.x.","journal-title":"Pigm Cell Res"},{"key":"1092_CR9","doi-asserted-by":"publisher","first-page":"1506","DOI":"10.1038\/s41436-021-01170-5","volume":"23","author":"E Legius","year":"2021","unstructured":"Legius E, Messiaen L, Wolkenstein P, Pancza P, Avery RA, Berman Y, et al. Revised diagnostic criteria for neurofibromatosis type 1 and Legius syndrome: an international consensus recommendation. Genet Med. 2021;23:1506\u201313. https:\/\/doi.org\/10.1038\/s41436-021-01170-5.","journal-title":"Genet Med"},{"key":"1092_CR10","doi-asserted-by":"publisher","first-page":"1893","DOI":"10.1007\/s00415-023-12127-w","volume":"271","author":"B Zhu","year":"2024","unstructured":"Zhu B, Zheng T, Wang W, Gu Y, Wei C, Li Q, et al. Genotype-phenotype correlations of neurofibromatosis type 1: a cross-sectional study from a large Chinese cohort. J Neurol. 2024;271:1893\u2013900. https:\/\/doi.org\/10.1007\/s00415-023-12127-w.","journal-title":"J Neurol"},{"key":"1092_CR11","unstructured":"Human Phenotype Ontology Consortium. Human Phenotype Ontology. 2025. https:\/\/hpo.jax.org\/. Accessed 9 Nov 2025."},{"key":"1092_CR12","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1038\/gim.2015.30","volume":"17","author":"S Richards","year":"2015","unstructured":"Richards S, Aziz N, Bale S, Bick D, Das S, Gastier-Foster J, et al. Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology. Genet Med. 2015;17:405\u201324. https:\/\/doi.org\/10.1038\/gim.2015.30.","journal-title":"Genet Med"},{"key":"1092_CR13","unstructured":"Department of Growth and Development, Capital Institute of Pediatrics. Height and weight standardized growth charts for Chinese children and adolescents aged 0 to 18 years. 2009. https:\/\/dx.chinadoi.cn\/10.3760\/cma.j.issn.0578-1310.2009.07.003. Accessed 9 Nov 2025."},{"key":"1092_CR14","doi-asserted-by":"publisher","first-page":"1084","DOI":"10.1016\/j.jaad.2016.12.012","volume":"76","author":"C Liy-Wong","year":"2017","unstructured":"Liy-Wong C, Mohammed J, Carleton A, Pope E, Parkin P, Lara-Corrales I. The relationship between neurofibromatosis type 1, juvenile xanthogranuloma, and malignancy: a retrospective case-control study. J Am Acad Dermatol. 2017;76:1084\u20137. https:\/\/doi.org\/10.1016\/j.jaad.2016.12.012.","journal-title":"J Am Acad Dermatol"},{"key":"1092_CR15","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1177\/0883073812446310","volume":"28","author":"EA Soucy","year":"2013","unstructured":"Soucy EA, van Oppen D, Nejedly NL, Gao F, Gutmann DH, Hollander AS. Height assessments in children with neurofibromatosis type 1. J Child Neurol. 2013;28:303\u20137. https:\/\/doi.org\/10.1177\/0883073812446310.","journal-title":"J Child Neurol"},{"key":"1092_CR16","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1002\/(sici)1096-8628(19991203)87:4<317::aid-ajmg7>3.0.co;2-x","volume":"87","author":"M Clementi","year":"1999","unstructured":"Clementi M, Milani S, Mammi I, Boni S, Monciotti C, Tenconi R. Neurofibromatosis type 1 growth charts. Am J Med Genet. 1999;87:317\u201323. https:\/\/doi.org\/10.1002\/(sici)1096-8628(19991203)87:4%3c317::aid-ajmg7%3e3.0.co;2-x.","journal-title":"Am J Med Genet"},{"key":"1092_CR17","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1016\/s0887-8994(00)00123-5","volume":"22","author":"R Vassilopoulou-Sellin","year":"2000","unstructured":"Vassilopoulou-Sellin R, Klein MJ, Slopis JK. Growth hormone deficiency in children with neurofibromatosis type 1 without suprasellar lesions. Pediatr Neurol. 2000;22:355\u20138. https:\/\/doi.org\/10.1016\/s0887-8994(00)00123-5.","journal-title":"Pediatr Neurol"},{"key":"1092_CR18","doi-asserted-by":"publisher","first-page":"96","DOI":"10.4274\/jcrpe.2070","volume":"8","author":"D Vurall\u0131","year":"2016","unstructured":"Vurall\u0131 D, G\u00f6n\u00e7 N, Vidaud D, \u00d6z\u00f6n A, Alika\u015fifo\u011flu A, Kandemir N. Growth hormone deficiency in a child with neurofibromatosis-noonan syndrome. J Clin Res Pediatr Endocrinol. 2016;8:96\u2013100. https:\/\/doi.org\/10.4274\/jcrpe.2070.","journal-title":"J Clin Res Pediatr Endocrinol"},{"key":"1092_CR19","doi-asserted-by":"publisher","first-page":"762","DOI":"10.1177\/0883073818786807","volume":"33","author":"NR Zessis","year":"2018","unstructured":"Zessis NR, Gao F, Vadlamudi G, Gutmann DH, Hollander AS. Height growth impairment in children with neurofibromatosis type 1 is characterized by decreased pubertal growth velocity in both sexes. J Child Neurol. 2018;33:762\u20136. https:\/\/doi.org\/10.1177\/0883073818786807.","journal-title":"J Child Neurol"},{"key":"1092_CR20","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1186\/s40673-018-0092-z","volume":"5","author":"MS Salman","year":"2018","unstructured":"Salman MS, Hossain S, Gorun S, Alqublan L, Bunge M, Rozovsky K. Cerebellar radiological abnormalities in children with neurofibromatosis type 1: part 2-a neuroimaging natural history study with clinical correlations. Cerebellum Ataxias. 2018;5:13. https:\/\/doi.org\/10.1186\/s40673-018-0092-z.","journal-title":"Cerebellum Ataxias"},{"key":"1092_CR21","doi-asserted-by":"publisher","first-page":"1733","DOI":"10.3174\/ajnr.A6740","volume":"41","author":"S Calvez","year":"2020","unstructured":"Calvez S, Levy R, Calvez R, Roux CJ, Gr\u00e9vent D, Purcell Y, et al. Focal areas of high signal intensity in children with neurofibromatosis type 1: expected evolution on MRI. AJNR Am J Neuroradiol. 2020;41:1733\u20139. https:\/\/doi.org\/10.3174\/ajnr.A6740.","journal-title":"AJNR Am J Neuroradiol"},{"key":"1092_CR22","doi-asserted-by":"publisher","first-page":"2333","DOI":"10.1007\/s00381-020-04710-7","volume":"36","author":"P Bernardo","year":"2020","unstructured":"Bernardo P, Cinalli G, Santoro C. Epilepsy in NF1: a systematic review of the literature. Childs Nerv Syst. 2020;36:2333\u201350. https:\/\/doi.org\/10.1007\/s00381-020-04710-7.","journal-title":"Childs Nerv Syst"},{"key":"1092_CR23","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1056\/NEJM199403033300903","volume":"330","author":"KM Shannon","year":"1994","unstructured":"Shannon KM, O\u2019Connell P, Martin GA, Paderanga D, Olson K, Dinndorf P, et al. Loss of the normal NF1 allele from the bone marrow of children with type 1 neurofibromatosis and malignant myeloid disorders. N Engl J Med. 1994;330:597\u2013601. https:\/\/doi.org\/10.1056\/NEJM199403033300903.","journal-title":"N Engl J Med"},{"key":"1092_CR24","doi-asserted-by":"publisher","first-page":"598","DOI":"10.1182\/asheducation-2016.1.598","volume":"2016","author":"H Hasle","year":"2016","unstructured":"Hasle H. Myelodysplastic and myeloproliferative disorders of childhood. Hematol Am Soc Hematol Educ Program. 2016;2016:598\u2013604. https:\/\/doi.org\/10.1182\/asheducation-2016.1.598.","journal-title":"Hematol Am Soc Hematol Educ Program"},{"key":"1092_CR25","doi-asserted-by":"publisher","first-page":"4314","DOI":"10.1182\/blood.V88.11.4314.bloodjournal88114314","volume":"88","author":"D Miles","year":"1996","unstructured":"Miles D, Freedman M, Stephens K, Pallavicini M, Sievers E, Weaver M, et al. Patterns of hematopoietic lineage involvement in children with neurofibromatosis type 1 and malignant myeloid disorders. Blood. 1996;88:4314\u201320.","journal-title":"Blood"},{"key":"1092_CR26","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1007\/s42000-022-00411-9","volume":"22","author":"SL Pinheiro","year":"2023","unstructured":"Pinheiro SL, Maciel J, Cavaco D, Figueiredo AA, Dam\u00e1sio IL, Donato S, et al. Precocious and accelerated puberty in children with neurofibromatosis type 1: results from a close follow-up of a cohort of 45 patients. Hormones. 2023;22:79\u201385. https:\/\/doi.org\/10.1007\/s42000-022-00411-9.","journal-title":"Hormones"},{"key":"1092_CR27","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejmg.2022.104474","volume":"65","author":"SK Ho","year":"2022","unstructured":"Ho SK, Luk HM, Ng SY, Yu KP, Cheng SS, Ng PP, et al. Old and new perspectives on neurofibromatosis type 1: clinical and molecular characterization of 832 patients from a single centre over 16 years. Eur J Med Genet. 2022;65:104474. https:\/\/doi.org\/10.1016\/j.ejmg.2022.104474.","journal-title":"Eur J Med Genet"},{"key":"1092_CR28","doi-asserted-by":"publisher","DOI":"10.3390\/cancers13081879","volume":"13","author":"M Scala","year":"2021","unstructured":"Scala M, Schiavetti I, Madia F, Chelleri C, Piccolo G, Accogli A, et al. Genotype-phenotype correlations in neurofibromatosis type 1: a single-center cohort study. Cancers. 2021;13:1879. https:\/\/doi.org\/10.3390\/cancers13081879.","journal-title":"Cancers"},{"key":"1092_CR29","doi-asserted-by":"publisher","first-page":"616","DOI":"10.1001\/archneur.59.4.616","volume":"59","author":"RL Billingsley","year":"2002","unstructured":"Billingsley RL, Schrimsher GW, Jackson EF, Slopis JM, Moore BD 3rd. Significance of planum temporale and planum parietale morphologic features in neurofibromatosis type 1. Arch Neurol. 2002;59:616\u201322. https:\/\/doi.org\/10.1001\/archneur.59.4.616.","journal-title":"Arch Neurol"},{"key":"1092_CR30","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1016\/j.pediatrneurol.2017.06.019","volume":"75","author":"V Robert-Boire","year":"2017","unstructured":"Robert-Boire V, Rosca L, Samson Y, Ospina LH, Perreault S. Clinical presentation and outcome of patients with optic pathway glioma. Pediatr Neurol. 2017;75:55\u201360. https:\/\/doi.org\/10.1016\/j.pediatrneurol.2017.06.019.","journal-title":"Pediatr Neurol"},{"key":"1092_CR31","doi-asserted-by":"publisher","DOI":"10.1186\/s13023-021-02121-8","volume":"16","author":"AM Henning","year":"2021","unstructured":"Henning AM, Handrup MM, Kjeldsen SM, Larsen DA, Ejerskov C. Optic pathway glioma and the sex association in neurofibromatosis type 1: a single-center study. Orphanet J Rare Dis. 2021;16:489. https:\/\/doi.org\/10.1186\/s13023-021-02121-8.","journal-title":"Orphanet J Rare Dis"},{"key":"1092_CR32","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1016\/j.pediatrneurol.2013.02.004","volume":"48","author":"JM Ko","year":"2013","unstructured":"Ko JM, Sohn YB, Jeong SY, Kim HJ, Messiaen LM. Mutation spectrum of NF1 and clinical characteristics in 78 Korean patients with neurofibromatosis type 1. Pediatr Neurol. 2013;48:447\u201353. https:\/\/doi.org\/10.1016\/j.pediatrneurol.2013.02.004.","journal-title":"Pediatr Neurol"},{"key":"1092_CR33","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejmg.2022.104609","volume":"65","author":"C Matas-Nadal","year":"2022","unstructured":"Matas-Nadal C, Soria X, Gonzalez-Farr\u00e9 M, Baradad M, Tuset N, Rius Riu F, et al. Abdominal tumors in patients with neurofibromatosis type I: genotype-phenotype relationships. Eur J Med Genet. 2022;65:104609. https:\/\/doi.org\/10.1016\/j.ejmg.2022.104609.","journal-title":"Eur J Med Genet"},{"key":"1092_CR34","doi-asserted-by":"publisher","DOI":"10.3390\/cancers15041217","volume":"15","author":"C Peduto","year":"2023","unstructured":"Peduto C, Zanobio M, Nigro V, Perrotta S, Piluso G, Santoro C. Neurofibromatosis type 1: pediatric aspects and review of genotype-phenotype correlations. Cancers (Basel). 2023;15:1217. https:\/\/doi.org\/10.3390\/cancers15041217.","journal-title":"Cancers (Basel)"},{"key":"1092_CR35","doi-asserted-by":"publisher","first-page":"1639","DOI":"10.1097\/cm9.0000000000003203","volume":"137","author":"B Zhu","year":"2024","unstructured":"Zhu B, Wang W, Gu Y, Wei C, Wang Z, Li Q. Genotype\u2013phenotype correlations and treatment innovation of neurofibromatosis type 1 (NF1): current understanding and perspective. Chin Med J. 2024;137:1639\u201341. https:\/\/doi.org\/10.1097\/cm9.0000000000003203.","journal-title":"Chin Med J"},{"key":"1092_CR36","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1007\/s00439-017-1766-y","volume":"136","author":"H Kehrer-Sawatzki","year":"2017","unstructured":"Kehrer-Sawatzki H, Mautner VF, Cooper DN. Emerging genotype-phenotype relationships in patients with large NF1 deletions. Hum Genet. 2017;136:349\u201376. https:\/\/doi.org\/10.1007\/s00439-017-1766-y.","journal-title":"Hum Genet"},{"key":"1092_CR37","doi-asserted-by":"publisher","first-page":"1052","DOI":"10.1002\/humu.22832","volume":"36","author":"K Rojnueangnit","year":"2015","unstructured":"Rojnueangnit K, Xie J, Gomes A, Sharp A, Callens T, Chen Y, et al. High incidence of Noonan syndrome features including short stature and pulmonic stenosis in patients carrying NF1 missense mutations affecting p.Arg1809: genotype-phenotype correlation. Hum Mutat. 2015;36:1052\u201363. https:\/\/doi.org\/10.1002\/humu.22832.","journal-title":"Hum Mutat"},{"key":"1092_CR38","doi-asserted-by":"publisher","first-page":"1510","DOI":"10.1002\/humu.22392","volume":"34","author":"A Sabbagh","year":"2013","unstructured":"Sabbagh A, Pasmant E, Imbard A, Luscan A, Soares M, Blanch\u00e9 H, et al. NF1 molecular characterization and neurofibromatosis type I genotype-phenotype correlation: the French experience. Hum Mutat. 2013;34:1510\u20138. https:\/\/doi.org\/10.1002\/humu.22392.","journal-title":"Hum Mutat"},{"key":"1092_CR39","doi-asserted-by":"publisher","DOI":"10.3390\/biomedicines13010146","volume":"13","author":"K Veres","year":"2025","unstructured":"Veres K, Nagy B, Ember Z, Bene J, Hadzsiev K, Medvecz M, et al. Increased phenotype severity associated with splice-site variants in a Hungarian pediatric neurofibromatosis 1 cohort: a retrospective study. Biomedicines. 2025;13:146. https:\/\/doi.org\/10.3390\/biomedicines13010146.","journal-title":"Biomedicines"}],"container-title":["World Journal of Pediatrics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12519-026-01092-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12519-026-01092-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12519-026-01092-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T15:18:20Z","timestamp":1790090300000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12519-026-01092-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,2]]},"references-count":39,"alternative-id":["1092"],"URL":"https:\/\/doi.org\/10.1007\/s12519-026-01092-9","relation":{},"ISSN":["1708-8569","1867-0687"],"issn-type":[{"value":"1708-8569","type":"print"},{"value":"1867-0687","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,2]]},"assertion":[{"value":"6 March 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 April 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 July 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 September 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 September 2026","order":6,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Update","order":7,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"In this article, Zhi_Ying Li, Xin Li, and Tian Wen should have been denoted as equally contributing authors.","order":8,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"No financial or non-financial benefits have been received or will be received from any party related directly or indirectly to the subject of this article.","order":1,"name":"Ethics","label":"Conflict of interest","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was approved by the Research Ethics Committee of Shanghai Children\u2019s Medical Center (SCMCIRB-K2024250-1), School of Medicine, Shanghai Jiao Tong University and was performed in accordance with all relevant guidelines and regulations (Declaration of Helsinki). Written informed consent was obtained from all participants or their guardians.","order":2,"name":"Ethics","label":"Ethics approval","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"During the preparation of this manuscript, we did not use any AI tools. No AI tools were used for study design, data analysis, interpretation of results, generation of scientific content, or manuscript preparation. All scientific content, analyses, conclusions, and interpretations are entirely original and were developed by the authors. The authors take full responsibility for the content of this publication.","order":3,"name":"Ethics","label":"AI usage statement","group":{"name":"EthicsHeading","label":"Declarations"}}]}}